Page last updated: 2024-09-22

kethoxal

Description

kethoxal: modifies guanine containing oligoribonucleotides by reacting selectively with guanine in polynucleotides. Drug is hydrate of 3-ethoxy-2-oxobutyraldehyde [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

1,1-dihydroxy-3-ethoxy-2-butanone : A butanone derivative having two hydroxy substituents at the 1-position and an ethoxy substituent at the 3-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID34006
CHEMBL ID2106348
CHEBI ID59052
SCHEMBL ID60738
MeSH IDM0046461

Synonyms (30)

Synonym
1,1-dihydroxy-3-ethoxy-2-butanone
3-ethoxy-1,1-dihydroxybutan-2-one
CHEBI:59052 ,
chetossale
ketoxalum
ketoxalum [inn-latin]
u 2032
3-ethoxy-1,1-dihydroxy-2-butanone
chetossale [dcit]
2-butanone, 3-ethoxy-1,1-dihydroxy-
beta-ethoxy-alpha-ketobutyraldehyde
ccris 5167
kethoxal [usan]
kethoxal
27762-78-3
kethoxal (usan/inn)
D04651
FT-0693443
AKOS006274955
mfcd00211044
unii-e00mdp82s4
ketoxal
ketoxal [inn]
u-2032
e00mdp82s4 ,
CHEMBL2106348
SCHEMBL60738
kethoxal [mi]
DTXSID90950449
Q25112687

Roles (1)

RoleDescription
antiinfective agentA substance used in the prophylaxis or therapy of infectious diseases.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
butanoneAny ketone that is butane substituted by an oxo group at unspecified position.
aldehyde hydrateA 1,1-diol resulting from the formal addition of water to the carbonyl group of a aldehyde.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (68)

TimeframeStudies, This Drug (%)All Drugs %
pre-199026 (38.24)18.7374
1990's21 (30.88)18.2507
2000's17 (25.00)29.6817
2010's1 (1.47)24.3611
2020's3 (4.41)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other68 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]